ArticleAdvanced biomedical research2022

Rational Design of a Hybrid Peptide against Severe Acute Respiratory Syndrome Coronavirus 2 Using Melittin and Angiotensin-Converting Enzyme 2 as Pharmaceutical Agents.

Ramin Farhoudi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.